Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
Ngo HX, Xu AY, Velásquez GE, Zhang N, Chang VK, Kurbatova EV, Whitworth WC, Sizemore E, Bryant K, Carr W, Weiner M, Dooley KE, Engle M, Dorman SE, Nahid P, Swindells S, Chaisson RE, Nsubuga P, Lourens M, Dawson R, Savic RM. Ngo HX, et al. Among authors: chaisson re. Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093/cid/ciae119. Online ahead of print. Clin Infect Dis. 2024. PMID: 38462673
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE; Tuberculosis Trials Consortium. Dorman SE, et al. Among authors: chaisson re. Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. doi: 10.1164/rccm.200901-0078OC. Epub 2009 Apr 30. Am J Respir Crit Care Med. 2009. PMID: 19406981 Clinical Trial.
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.
Sterling TR, Moro RN, Borisov AS, Phillips E, Shepherd G, Adkinson NF, Weis S, Ho C, Villarino ME; Tuberculosis Trials Consortium. Sterling TR, et al. Clin Infect Dis. 2015 Aug 15;61(4):527-35. doi: 10.1093/cid/civ323. Epub 2015 Apr 22. Clin Infect Dis. 2015. PMID: 25904367 Free PMC article. Clinical Trial.
Facilitators and barriers to adolescent participation in a TB clinical trial.
Mangan JM, Hedges KNC, Salerno MM, Tatum K, Bouwkamp B, Frick MW, McKenna L, Muzanyi G, Engle M, Coetzee J, Yvetot J, Elskamp M, Lamunu D, Tizora MET, Namutamba D, Chaisson RE, Swindells S, Nahid P, Dorman SE, Kurbatova E. Mangan JM, et al. Among authors: chaisson re. Int J Tuberc Lung Dis. 2024 May 1;28(5):243-248. doi: 10.5588/ijtld.23.0519. Int J Tuberc Lung Dis. 2024. PMID: 38659142
Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.
Dorjee K, Namdon T, Topgyal S, Gyatso U, Tsundue T, Dolma T, Kumar V, Lhadon D, Yangkyi T, Khachoe T, Dorjee S, Sadoff RC, Peters D, Gupta A, Paster Z, Chaisson RE, Phunkyi D, Sadutshang TD. Dorjee K, et al. Among authors: chaisson re. Vaccine. 2024 Jun 11;42(16):3572-3577. doi: 10.1016/j.vaccine.2024.04.063. Epub 2024 Apr 27. Vaccine. 2024. PMID: 38679512
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil.
Patel MA, Durovni B, Salazar-Austin N, Cavalcante SC, Golub JE, Chaisson RE, Chaisson LH, Saraceni V. Patel MA, et al. Among authors: chaisson re. Int J Tuberc Lung Dis. 2024 May 1;28(5):259-261. doi: 10.5588/ijtld.23.0487. Int J Tuberc Lung Dis. 2024. PMID: 38659145 No abstract available.
Restocking the tuberculosis drug arsenal.
Nuermberger EL, Chaisson RE. Nuermberger EL, et al. Among authors: chaisson re. Nat Med. 2024 Mar;30(3):642-643. doi: 10.1038/s41591-024-02840-y. Nat Med. 2024. PMID: 38459183 No abstract available.
447 results